ACC 2018Conferences CANTOS Trial: Canakinumab Reduces MACE and Mortality Among CKD Patients Tarek Nafee, M.D. Share 0 Min Read http://cardiologynownews.org/wp-content/uploads/2018/03/sun_1130_gibson_ridker.mp4 TAGGED:Featured Share This Article Copy Link Print Leave a Comment Leave a Reply Cancel replyYou must be logged in to post a comment.
